KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EBIT: 2009-2024

Historic EBIT for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • Idexx Laboratories' EBIT rose 16.77% to $354.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 17.46%. This contributed to the annual value of $1.1 billion for FY2024, which is 2.84% up from last year.
  • As of FY2024, Idexx Laboratories' EBIT stood at $1.1 billion, which was up 2.84% from $1.1 billion recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' EBIT peaked at $1.1 billion during FY2024, and registered a low of $694.5 million during FY2020.
  • In the last 3 years, Idexx Laboratories' EBIT had a median value of $1.1 billion in 2023 and averaged $1.0 billion.
  • In the last 5 years, Idexx Laboratories' EBIT spiked by 34.20% in 2021 and then decreased by 3.57% in 2022.
  • Idexx Laboratories' EBIT (Yearly) stood at $694.5 million in 2020, then skyrocketed by 34.20% to $932.0 million in 2021, then decreased by 3.57% to $898.8 million in 2022, then grew by 22.07% to $1.1 billion in 2023, then rose by 2.84% to $1.1 billion in 2024.